CID 71566267

Nivasorexant

Structural Information

Molecular Formula
C23H23N7O2
SMILES
CC1=CC(=C(C=C1)C(=O)N2CCOC[C@H]2CC3=CC(=CC=C3)N4N=CC=N4)N5N=CC=N5
InChI
InChI=1S/C23H23N7O2/c1-17-5-6-21(22(13-17)30-26-9-10-27-30)23(31)28-11-12-32-16-20(28)15-18-3-2-4-19(14-18)29-24-7-8-25-29/h2-10,13-14,20H,11-12,15-16H2,1H3/t20-/m1/s1
InChIKey
GKPHAIOJCHBZCT-HXUWFJFHSA-N
Compound name
[4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

4
References

33
Patents

429.1913 Da
Monoisotopic Mass

3.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 430.19858 200.9
[M+Na]+ 452.18052 208.2
[M-H]- 428.18402 208.9
[M+NH4]+ 447.22512 202.0
[M+K]+ 468.15446 201.6
[M+H-H2O]+ 412.18856 186.4
[M+HCOO]- 474.18950 213.2
[M+CH3COO]- 488.20515 207.8
[M+Na-2H]- 450.16597 198.2
[M]+ 429.19075 200.5
[M]- 429.19185 200.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe